4basebio Plc

4basebio (4BB)

[ADVERT]
Company name:4basebio Plc
EPIC:4BBTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BMCLYF79
Market Segment:ASQ1Share Type:DE
WWW Address:https://www.4basebio.com/investors/Description:ORD EUR1.00
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 595.00 images.advfn.com/imagesnew/2/gb/down -15.0 [-2.46] 580.00 610.00 610.00 610.00 595.00 2,869
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 73.29 12.32 - -8.00 - - - 687.50 - 147.50

4basebio Key Figures

(at previous day's close)
Market Cap.73.29m
Shares In Issue12.32m
Prev. Close610.00
PE Ratio- 
Dividend Yield-%
EPS - basic-8.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-8.30p
Return On Equity (ROE)-4.65%
Operating Margin-154.98%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt-12.65m
Gross Gearing13.20%
Quick Assets15.38m
Net Working Capital14.70m
Intangibles / Fixed Assets34.18%
Turnover PS3.75p
Pre-Tax Profit PS-5.81p
Retained Profit PS-5.84p
Cash PS121.79p
Net Cash PS115.19p
Net Tangible Asset Value PS *119.12p
Net Asset Value PS125.50p
Spread30.00 (4.92%) 

4basebio Balance Sheet

L^4BB:Liabilities+EQL^4BB:Assets

Share Price Performance

Sample Period HighLow
1 week615.00477.50
4 weeks615.00457.50
12 weeks615.00365.00
1 year687.50147.50

Share Price Chart (5 years)

4basebio Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week477.50117.5024.61477.500.01572.28
4 weeks464.50130.5028.09457.500.01492.24
12 weeks365.00230.0063.01365.000.01431.49
26 weeks147.50447.50303.39147.500.01393.87
1 year147.50447.50303.39147.500.01393.87
3 years147.50447.50303.39147.500.01393.87
5 years147.50447.50303.39147.500.01393.87

4basebio Key Management Ratios

4basebio Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 4.12 
Tobin's Q Ratio (excl. intangibles)4.31 
Dividend Yield-%
Market-to-Book Ratio4.74 
Price-to-Pre-Tax Profit PS-102.36 
Price-to-Retained Profit PS-101.93 
Price-to-Cash Flow PS-71.71 
Price-to-Sales PS158.63 
Price-to-Net Tangible Asset Value PS4.99 
Price-to-Cash PS4.89 
Net Working Capital PS119.33 
Price Pct to Working Capital PS4.99%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

4basebio Financial Ratios

(Leverage Ratios)
Debt Ratio9.05%
Debt-to-Equity Ratio0.10 
Debt-to-Equity Ratio (excl. Intgbl)0.10 
Debt-to-Equity Market Value0.02 
Net Gearing-71.03%
Net Gearing (excl. Intangibles)-74.31%
Gross Gearing13.20%
Gross Gearing (excl. Intangibles)13.81%
Gearing Under 1 Year4.57%
Gearing Under 1 Year (excl. Intgbl)4.78%
Assets/Equity1.15 
Cash/Equity97.04 
(Liquidity Ratios)
Net Working Capital to Total Assets82.54%
Current Ratio19.08 
Quick Ratio (Acid Test)18.92 
Liquidity Ratio18.45 
Cash & Equiv/Current Assets96.71%
(Solvency Ratios)
Enterprise Value59.83m
CFO/Sales-2.21 
CFO/Attributable Profit- 
CFO/Assets-0.06 
CFO/Debt-0.43 
Total Debt/Equity Market Value0.03 
Total Debt/Sales5.09 
Total Debt/Pre-Tax Profit-3.28 
Total Debt2.35m
Total Debt/Net Current Assets0.16%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
Sorry No Data AvailableSorry No Data Available

4basebio Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-4.21%
Return On Assets (ROA)-4.04%
Net Profit Margin-155.63%
Assets Turnover0.03 
Return On Equity (ROE)-4.65%
Return On Investment (ROI)-4.23%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-155.63%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.03 
Fixed Assets Turnover0.20 
Current Assets Turnover0.03 
Net Working Capital Turnover 
Inventory Turnover3.53 
(Other Operating Ratios)
Total Assets-to-Sales38.55 
Debtors-to-Sales8.44%
Debt Collection Period30.81Days

4basebio Dividends

Sorry No Data Available

4basebio Fundamentals

 31 Dec 2020 (GBP)
turnover0.46-m
pre tax profit-0.72-m
attributable profit-0.72-m
retained profit-0.72-m
eps - basic (p)-8.00 
eps - diluted (p)-8.00 
dividends per share- 

4basebio Balance Sheet

 31 Dec 2020 (GBP)
L^4BB:Liabilities+EQL^4BB:Assets
 31 Dec 2020 (GBP)
ASSETS
fixed assets fixed assets1.488.30%m
intangibles intangibles0.794.41%m
fixed investments fixed investments0.030.19%m
current assets - other current assets - other0.341.91%m
stocks stocks0.130.74%m
debtors debtors0.040.22%m
cash & securities cash & securities15.0084.23%m
TOTAL17.81100%m
LIABILITIES
creditors - short creditors - short0.814.57%m
creditors - long creditors - long1.548.64%m
creditors - other creditors - other--%m
subordinated loans subordinated loans--%m
insurance funds insurance funds--%m
TOTAL2.3513.20%m
EQUITY
ord cap, reserves ord cap, reserves15.4686.80%m
prefs, minorities prefs, minorities--%m
TOTAL15.4686.80%m
OTHER
NAV Basic- 
NAV Diluted- 

4basebio Cash Flow Statement

31 Dec 2020 (GBP)
Operating CF-1.02m
Pre-Financing CF0.42m
Retained CF14.85m

4basebio Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
4BB
4basebio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210805 11:23:18